Different associations of estrogen receptor β isoforms, ERβ1 and ERβ2, expression levels with tumor size and survival in early- and late-onset breast cancer

Cancer Letters

Volumn 321, Issue 1, 2012, Pages 73-79

  Mandusic, Vesna ^a,b   Dimitrijevic, Bogomir ^b   Nikolic Vukosavljevic, Dragica ^c   Neskovic Konstantinovic, Zora ^c   Kanjer, Ksenija ^c   Hamann, Ute ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Clinical outcome; Early and late onset breast cancers; Estrogen receptor alpha; Estrogen receptor beta; Quantitative RT PCR

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGEN RECEPTOR BETA 1; ESTROGEN RECEPTOR BETA 2; GONADORELIN DERIVATIVE; MESSENGER RNA; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; PROTEIN PS2; TAMOXIFEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER PROGNOSIS; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; FEMALE; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONSET AGE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGESTERONE RECEPTOR GENE; PS2 GENE; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MIDDLE AGED; PROGNOSIS; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 84860345854     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.02.022     Document Type: Article

References (57)

1. Henderson B.E., Ross R., Bernstein L. Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal foundation award lecture. Cancer Res. 1988, 48:246-253.
2. Green S., Walter P., Kumar V., Krust A., Bornert J.M., Argos P., Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986, 320:134-139.
3. Greene G.L., Gilna P., Waterfield M., Baker A., Hort Y., Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986, 231:1150-1154. (New York, NY).
4. Kuiper G.G., Enmark E., Pelto-Huikko M., Nilsson S., Gustafsson J.A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Nat. Acad. Sci. USA 1996, 93:5925-5930.
5. Saville B., Wormke M., Wang F., Nguyen T., Enmark E., Kuiper G., Gustafsson J.A., Safe S. Ligand-, cell-, and estrogen receptor subtype (alpha/beta)-dependent activation at GC-rich (Sp1) promoter elements. J. Biol. Chem. 2000, 275:5379-5387.
6. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., Webb P. Estrogen receptor pathways to AP-1. The J. Steroid Biochem. Mol. Biol. 2000, 74:311-317.
7. Chu S., Nishi Y., Yanase T., Nawata H., Fuller P.J. Transrepression of estrogen receptor beta signaling by nuclear factor-kappab in ovarian granulosa cells. Mol. Endocrinol. 2004, 18:1919-1928. (Baltimore, Md).
8. Pettersson K., Grandien K., Kuiper G.G., Gustafsson J.A. Mouse estrogen receptor beta forms estrogen response element-binding heterodimers with estrogen receptor alpha. Mol. Endocrinol. 1997, 11:1486-1496. (Baltimore, Md).
9. Maruyama S., Fujimoto N., Asano K., Ito A. Suppression by estrogen receptor beta of AP-1 mediated transactivation through estrogen receptor alpha. The J. Steroid Biochem. Mol. Biol. 2001, 78:177-184.
10. Lin C.Y., Strom A., Li Kong S., Kietz S., Thomsen J.S., Tee J.B., Vega V.B., Miller L.D., Smeds J., Bergh J., Gustafsson J.A., Liu E.T. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer. Breast Cancer Res. 2007, 9:R25.
11. Chang E.C., Frasor J., Komm B., Katzenellenbogen B.S. Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 2006, 147:4831-4842.
12. Park B.W., Kim K.S., Heo M.K., Yang W.I., Kim S.I., Kim J.H., Kim G.E., Lee K.S. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: decrease of estrogen receptor-beta2 expression is the key event in breast cancer development. J. Surg. Oncol. 2006, 93:504-510.
13. Bardin A., Boulle N., Lazennec G., Vignon F., Pujol P. Loss of ERbeta expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer 2004, 11:537-551.
14. Peng B., Lu B., Leygue E., Murphy L.C. Putative functional characteristics of human estrogen receptor-beta isoforms. J. Mol. Endocrinol. 2003, 30:13-29.
15. Zhao C., Matthews J., Tujague M., Wan J., Strom A., Toresson G., Lam E.W., Cheng G., Gustafsson J.A., Dahlman-Wright K. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells. Cancer Res. 2007, 67:3955-3962.
16. Ogawa S., Inoue S., Watanabe T., Orimo A., Hosoi T., Ouchi Y., Muramatsu M. Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human. Nucleic Acids Res. 1998, 26:3505-3512.
17. Gruvberger-Saal S.K., Bendahl P.O., Saal L.H., Laakso M., Hegardt C., Eden P., Peterson C., Malmstrom P., Isola J., Borg A., Ferno M. Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma. Clin. Cancer Res. 2007, 13:1987-1994.
18. Speirs V., Parkes A.T., Kerin M.J., Walton D.S., Carleton P.J., Fox J.N., Atkin S.L. Coexpression of estrogen receptor alpha and beta: poor prognostic factors in human breast cancer?. Cancer Res. 1999, 59:525-528.
19. Honma N., Horii R., Iwase T., Saji S., Younes M., Takubo K., Matsuura M., Ito Y., Akiyama F., Sakamoto G. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy. J. Clin. Oncol. 2008, 26:3727-3734.
20. Shaaban A.M., Green A.R., Karthik S., Alizadeh Y., Hughes T.A., Harkins L., Ellis I.O., Robertson J.F., Paish E.C., Saunders P.T., Groome N.P., Speirs V. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Clin. Cancer Res. 2008, 14:5228-5235.
21. Honma N., Saji S., Kurabayashi R., Aida J., Arai T., Horii R., Akiyama F., Iwase T., Harada N., Younes M., Toi M., Takubo K., Sakamoto G. Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast. APMIS 2008, 116:923-930.
22. Vinayagam R., Sibson D.R., Holcombe C., Aachi V., Davies M.P. Association of oestrogen receptor beta 2 (ER beta 2/ER beta cx) with outcome of adjuvant endocrine treatment for primary breast cancer - a retrospective study. BMC Cancer 2007, 7:131.
23. Matthews J., Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol. Interv. 2003, 3:281-292.
24. Pettersson K., Delaunay F., Gustafsson J.A. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 2000, 19:4970-4978.
25. Esslimani-Sahla M., Simony-Lafontaine J., Kramar A., Lavaill R., Mollevi C., Warner M., Gustafsson J.A., Rochefort H. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. Clin. Cancer Res. 2004, 10:5769-5776.
26. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987, 162:156-159.
27. Bulun S.E., Cheng Y.H., Pavone M.E., Xue Q., Attar E., Trukhacheva E., Tokunaga H., Utsunomiya H., Yin P., Luo X., Lin Z., Imir G., Thung S., Su E.J., Kim J.J. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis. Semin. Reprod. Med. 2010, 28:36-43.
28. Omoto Y., Eguchi H., Yamamoto-Yamaguchi Y., Hayashi S. Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7. Oncogene 2003, 22:5011-5020.
29. Yau C., Fedele V., Roydasgupta R., Fridlyand J., Hubbard A., Gray J.W., Chew K., Dairkee S.H., Moore D.H., Schittulli F., Tommasi S., Paradiso A., Albertson D.G., Benz C.C. Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers. Breast Cancer Res. 2007, 9:R59.
30. Quong J., Eppenberger-Castori S., Moore D., Scott G.K., Birrer M.J., Kueng W., Eppenberger U., Benz C.C. Age-dependent changes in breast cancer hormone receptors and oxidant stress markers. Breast Cancer Res. Treat. 2002, 76:221-236.
31. Ogawa S., Inoue S., Watanabe T., Hiroi H., Orimo A., Hosoi T., Ouchi Y., Muramatsu M. The complete primary structure of human estrogen receptor beta (hER beta) and its heterodimerization with ER alpha in vivo and in vitro. Biochem. Biophys. Res. Commun. 1998, 243:122-126.
32. Hayashi S.I., Eguchi H., Tanimoto K., Yoshida T., Omoto Y., Inoue A., Yoshida N., Yamaguchi Y. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr. Relat. Cancer 2003, 10:193-202.
33. Saji S., Omoto Y., Shimizu C., Warner M., Hayashi Y., Horiguchi S., Watanabe T., Hayashi S., Gustafsson J.A., Toi M. Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor. Cancer Res. 2002, 62:4849-4853.
34. Eppenberger-Castori S., Moore D.H., Thor A.D., Edgerton S.M., Kueng W., Eppenberger U., Benz C.C. Age-associated biomarker profiles of human breast cancer. Int. J. Biochem. Cell Biol. 2002, 34:1318-1330.
35. Nikolic-Vukosavljevic D., Vasiljevic N., Brankovic-Magic M., Polic D. Variations in steroid hormone receptor content throughout age and menopausal periods, and menstrual cycle in breast cancer patients. Neoplasma 1996, 43:163-169.
36. Yoshida T., Eguchi H., Nakachi K., Tanimoto K., Higashi Y., Suemasu K., Iino Y., Morishita Y., Hayashi S. Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors. Carcinogenesis 2000, 21:2193-2201.
37. Hayashi S., Imai K., Suga K., Kurihara T., Higashi Y., Nakachi K. Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis 1997, 18:459-464.
38. Tanimoto K., Eguchi H., Yoshida T., Hajiro-Nakanishi K., Hayashi S. Regulation of estrogen receptor alpha gene mediated by promoter B responsible for its enhanced expression in human breast cancer. Nucleic Acids Res. 1999, 27:903-909.
39. Holst F., Stahl P.R., Ruiz C., Hellwinkel O., Jehan Z., Wendland M., Lebeau A., Terracciano L., Al-Kuraya K., Janicke F., Sauter G., Simon R. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat. Genet. 2007, 39:655-660.
40. Lazennec G., Bresson D., Lucas A., Chauveau C., Vignon F. ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 2001, 142:4120-4130.
41. Brouillet J.P., Dujardin M.A., Chalbos D., Rey J.M., Grenier J., Lamy P.J., Maudelonde T., Pujol P. Analysis of the potential contribution of estrogen receptor (ER) beta in ER cytosolic assay of breast cancer. Int. J. Cancer 2001, 95:205-208.
42. Cui X., Schiff R., Arpino G., Osborne C.K., Lee A.V. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J. Clin. Oncol. 2005, 23:7721-7735.
43. Mandusic V., Nikolic-Vukosavljevic D., Tanic N., Kanjer K., Neskovic-Konstantinovic Z., Celeketic D., Dimitrijevic B. Expression of estrogen receptor beta wt isoform (ERbeta1) and ERbetaDelta5 splice variant mRNAs in sporadic breast cancer. J. Cancer Res. Clin. Oncol. 2007, 133:571-579.
44. Speirs V., Malone C., Walton D.S., Kerin M.J., Atkin S.L. Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients. Cancer Res. 1999, 59:5421-5424.
45. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997, 277:1508-1510. (New York, NY).
46. Schnitt S.J. Estrogen receptor testing of breast cancer in current clinical practice. What's the question?. J. Clin. Oncol. 2006, 24:1797-1799.
47. Cullen R., Maguire T.M., McDermott E.W., Hill A.D., O'Higgins N.J., Duffy M.J. Studies on oestrogen receptor-alpha and -beta mRNA in breast cancer. Eur. J. Cancer 2001, 37:1118-1122.
48. O'Neill P.A., Davies M.P., Shaaban A.M., Innes H., Torevell A., Sibson D.R., Foster C.S. Wild-type oestrogen receptor beta (ERbeta1) mRNA and protein expression in tamoxifen-treated post-menopausal breast cancers. Br. J. Cancer 2004, 91:1694-1702.
49. Poola I., Fuqua S.A., De Witty R.L., Abraham J., Marshallack J.J., Liu A. Estrogen receptor alpha-negative breast cancer tissues express significant levels of estrogen-independent transcription factors, ERbeta1 and ERbeta5: potential molecular targets for chemoprevention. Clin. Cancer Res. 2005, 11:7579-7585.
50. Davies M.P., O'Neill P.A., Innes H., Sibson D.R., Prime W., Holcombe C., Foster C.S. Correlation of mRNA for oestrogen receptor beta splice variants ERbeta1, ERbeta2/ERbetacx and ERbeta5 with outcome in endocrine-treated breast cancer. J. Mol. Endocrinol. 2004, 33:773-782.
51. Sugiura H., Toyama T., Hara Y., Zhang Z., Kobayashi S., Fujii Y., Iwase H., Yamashita H. Expression of estrogen receptor beta wild-type and its variant ER{beta}cx/{beta}2 is correlated with better prognosis in breast cancer. Jpn. J. Clin. Oncol. 2007.
52. Skliris G.P., Parkes A.T., Limer J.L., Burdall S.E., Carder P.J., Speirs V. Evaluation of seven oestrogen receptor beta antibodies for immunohistochemistry, western blotting, and flow cytometry in human breast tissue. J. Pathol. 2002, 197:155-162.
53. Weitsman G.E., Skliris G., Ung K., Peng B., Younes M., Watson P.H., Murphy L.C. Assessment of multiple different estrogen receptor-beta antibodies for their ability to immunoprecipitate under chromatin immunoprecipitation conditions. Breast Cancer Res. Treat. 2006, 100:23-31.
54. Skliris G.P., Leygue E., Watson P.H., Murphy L.C. Estrogen receptor alpha negative breast cancer patients: estrogen receptor beta as a therapeutic target. The J. Steroid Biochem. Mol. Biol. 2008, 109:1-10.
55. Jensen E.V., Cheng G., Palmieri C., Saji S., Makela S., Van Noorden S., Wahlstrom T., Warner M., Coombes R.C., Gustafsson J.A. Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc. Nat. Acad. Sci. USA 2001, 98:15197-15202.
56. Speirs V., Skliris G.P., Burdall S.E., Carder P.J. Distinct expression patterns of ER alpha and ER beta in normal human mammary gland. J. Clin. Pathol. 2002, 55:371-374.
57. Cummings M., Iremonger J., Green C.A., Shaaban A.M., Speirs V. Gene expression of ER beta isoforms in laser microdissected human breast cancers: implications for gene expression analyses. Cell Oncol. 2009, 31:467-473.